{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T04:40:34Z","timestamp":1791434434690,"version":"4.3.3"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,30]],"date-time":"2024-01-30T00:00:00Z","timestamp":1706572800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006364","name":"French National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006364","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thegreenjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.radonc.2024.110116","type":"journal-article","created":{"date-parts":[[2024,2,3]],"date-time":"2024-02-03T03:16:07Z","timestamp":1706930167000},"page":"110116","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Cost-effectiveness of weekly adaptive radiotherapy versus standard IMRT in head and neck cancer alongside the ARTIX trial"],"prefix":"10.1016","volume":"193","author":[{"given":"Lionel","family":"Perrier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Balusson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magali","family":"Morelle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00ebl","family":"Castelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliette","family":"Thariat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Benezery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Hasbini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Gery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Berger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Liem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9bastien","family":"Guihard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Chapet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9bastien","family":"Thureau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Auberdiac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Pommier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amandine","family":"Ruffier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Devillers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Oger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boris","family":"Campillo-Gimenez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renaud","family":"de Crevoisier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2024.110116_b0005","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1056\/NEJMoa053422","article-title":"Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck","volume":"354","author":"Bonner","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.radonc.2024.110116_b0010","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S1470-2045(09)70311-0","article-title":"Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival","volume":"11","author":"Bonner","year":"2010","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.radonc.2024.110116_b0015","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0140-6736(18)32779-X","article-title":"Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial","volume":"393","author":"Gillison","year":"2019","journal-title":"Lancet Lond Engl"},{"key":"10.1016\/j.radonc.2024.110116_b0020","doi-asserted-by":"crossref","first-page":"4873","DOI":"10.1200\/JCO.2007.11.5501","article-title":"Prospective randomized study of intensity-modulated radiotherapy on salivary gland function in early-stage nasopharyngeal carcinoma patients","volume":"25","author":"Kam","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2024.110116_b0025","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S1470-2045(10)70290-4","article-title":"Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial","volume":"12","author":"Nutting","year":"2011","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.radonc.2024.110116_b0030","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.ijrobp.2006.06.013","article-title":"Xerostomia and quality of life after intensity-modulated radiotherapy vs. conventional radiotherapy for early-stage nasopharyngeal carcinoma: initial report on a randomized controlled clinical trial","volume":"66","author":"Pow","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2024.110116_b0035","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.radonc.2018.02.021","article-title":"Submandibular function recovery after IMRT in head and neck cancer: a prospective dose modelling study","volume":"129","author":"Murthy","year":"2018","journal-title":"Radiother Oncol J Eur Soc Ther Radiol Oncol"},{"key":"10.1016\/j.radonc.2024.110116_b0040","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1080\/0284186X.2018.1505053","article-title":"Adaptive radiotherapy for head and neck cancer","volume":"57","author":"Castelli","year":"2018","journal-title":"Acta Oncol Stockh Swed"},{"key":"10.1016\/j.radonc.2024.110116_b0045","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s13014-014-0318-z","article-title":"Impact of head and neck cancer adaptive radiotherapy to spare the parotid glands and decrease the risk of xerostomia","volume":"10","author":"Castelli","year":"2015","journal-title":"Radiat Oncol Lond Engl"},{"key":"10.1016\/j.radonc.2024.110116_b0050","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.ijrobp.2010.03.014","article-title":"Adaptive planning in intensity-modulated radiation therapy for head and neck cancers: single-institution experience and clinical implications","volume":"80","author":"Ahn","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2024.110116_b0055","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.ijrobp.2010.10.072","article-title":"A clinical concept for interfractional adaptive radiation therapy in the treatment of head and neck cancer","volume":"82","author":"Jensen","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2024.110116_b0060","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.radonc.2010.10.009","article-title":"The role of replanning in fractionated intensity modulated radiotherapy for nasopharyngeal carcinoma","volume":"98","author":"Zhao","year":"2011","journal-title":"Radiother Oncol J Eur Soc Ther Radiol Oncol"},{"key":"10.1016\/j.radonc.2024.110116_b0065","doi-asserted-by":"crossref","first-page":"20160085","DOI":"10.1259\/bjr.20160085","article-title":"Clinical outcomes of adaptive radiotherapy in head and neck cancers","volume":"89","author":"Kataria","year":"2016","journal-title":"Br J Radiol"},{"key":"10.1016\/j.radonc.2024.110116_b0070","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.ijrobp.2011.08.017","article-title":"Adaptive radiotherapy for head-and-neck cancer: initial clinical outcomes from a prospective trial","volume":"83","author":"Schwartz","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2024.110116_b0075","doi-asserted-by":"crossref","DOI":"10.1001\/jamaoncol.2023.1352","article-title":"Weekly adaptive radiotherapy vs standard intensity-modulated radiotherapy for improving salivary function in patients with head and neck cancer: a phase 3 randomized clinical trial","author":"Castelli","year":"2023","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.radonc.2024.110116_b0080","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1034\/j.1601-0825.2002.02851.x","article-title":"Saliva and gastrointestinal functions of taste, mastication, swallowing and digestion","volume":"8","author":"Pedersen","year":"2002","journal-title":"Oral Dis"},{"key":"10.1016\/j.radonc.2024.110116_b0085","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1097\/MLR.0000000000001745","article-title":"The economic burden of disease in France from the national health insurance perspective: the healthcare expenditures and conditions mapping used to prepare the french social security funding act and the public health act","volume":"60","author":"Rachas","year":"2022","journal-title":"Med Care"},{"key":"10.1016\/j.radonc.2024.110116_b0090","doi-asserted-by":"crossref","unstructured":"Dr\u00e9zen E, Happe A, Kerbrat S, Balusson F, Oger E. New metrics for assessing linkage quality in deterministic record linkage of health databases; 2022. https:\/\/hal.science\/hal-03601245 [accessed January 21, 2024].","DOI":"10.1016\/j.respe.2022.09.068"},{"key":"10.1016\/j.radonc.2024.110116_b0095","unstructured":"French National Authority for Health (HAS). Choices in methods for economic evaluation \u2013 HAS; 2020. https:\/\/www.has-sante.fr\/upload\/docs\/application\/pdf\/2020-11\/methodological_guidance_2020_-choices_in_methods_for_economic_evaluation.pdf. [accessed January 21, 2024]."},{"key":"10.1016\/j.radonc.2024.110116_b0100","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1177\/0272989X9001000308","article-title":"The CE plane: a graphic representation of cost-effectiveness","volume":"10","author":"Black","year":"1990","journal-title":"Med Decis Mak Int J Soc Med Decis Mak"},{"key":"10.1016\/j.radonc.2024.110116_b0105","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/1472-6963-6-52","article-title":"Using and interpreting cost-effectiveness acceptability curves: an example using data from a trial of management strategies for atrial fibrillation","volume":"6","author":"Fenwick","year":"2006","journal-title":"BMC Health Serv Res"},{"key":"10.1016\/j.radonc.2024.110116_b0110","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1002\/hec.903","article-title":"Cost-effectiveness acceptability curves\u2013facts, fallacies and frequently asked questions","volume":"13","author":"Fenwick","year":"2004","journal-title":"Health Econ"},{"key":"10.1016\/j.radonc.2024.110116_b0115","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jval.2021.11.1351","article-title":"Consolidated health economic evaluation reporting standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluations","volume":"25","author":"Husereau","year":"2022","journal-title":"Value Health J Int Soc Pharmacoecon Outcomes Res"},{"key":"10.1016\/j.radonc.2024.110116_b0120","doi-asserted-by":"crossref","first-page":"e833","DOI":"10.1016\/S2214-109X(23)00162-6","article-title":"Determining the efficiency path to universal health coverage: cost-effectiveness thresholds for 174 countries based on growth in life expectancy and health expenditures","volume":"11","author":"Pichon-Riviere","year":"2023","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.radonc.2024.110116_b0125","first-page":"622","article-title":"Adaptive radiation therapy: when, how and what are the benefits that literature provides?","volume":"26","author":"Avgousti","year":"2022","journal-title":"Cancer Radiother J Soc Francaise Radiother Oncol"},{"key":"10.1016\/j.radonc.2024.110116_b0130","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1017\/S0266462320000677","article-title":"Cost-effectiveness of treating head and neck cancer using intensity-modulated radiation therapy: implications for cancer control program in India","volume":"36","author":"Chauhan","year":"2020","journal-title":"Int J Technol Assess Health Care"},{"key":"10.1016\/j.radonc.2024.110116_b0135","series-title":"Intensity modulated radiation therapy","author":"Clark","year":"2012"},{"key":"10.1016\/j.radonc.2024.110116_b0140","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.ijrobp.2013.08.011","article-title":"Two-year and lifetime cost-effectiveness of intensity modulated radiation therapy versus 3-dimensional conformal radiation therapy for head-and-neck cancer","volume":"87","author":"Kohler","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2024.110116_b0145","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1186\/s12885-021-08638-2","article-title":"Optimizing oropharyngeal cancer management by using proton beam therapy: trends of cost-effectiveness","volume":"21","author":"Li","year":"2021","journal-title":"BMC Cancer"},{"key":"10.1016\/j.radonc.2024.110116_b0150","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.ijrobp.2018.04.018","article-title":"Cost-effectiveness analysis of intensity modulated radiation therapy versus proton therapy for oropharyngeal squamous cell carcinoma","volume":"101","author":"Sher","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2024.110116_b0155","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/s13014-023-02327-z","article-title":"The cost effectiveness of intensity-modulated radiation therapy and three-dimensional conformal radiotherapy in the treatment of head and neck cancers","volume":"18","author":"Varmaghani","year":"2023","journal-title":"Radiat Oncol Lond Engl"},{"key":"10.1016\/j.radonc.2024.110116_b0160","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.clon.2012.05.010","article-title":"Cost-effectiveness of intensity-modulated radiotherapy in oropharyngeal cancer","volume":"24","author":"Yong","year":"2012","journal-title":"Clin Oncol R Coll Radiol G B"},{"key":"10.1016\/j.radonc.2024.110116_b0165","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.jval.2021.08.014","article-title":"The use of cost-effectiveness thresholds for evaluating health interventions in low- and middle-income countries from 2015 to 2020: a review","volume":"25","author":"Kazibwe","year":"2022","journal-title":"Value Health J Int Soc Pharmacoecon Outcomes Res"},{"key":"10.1016\/j.radonc.2024.110116_b0170","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s10198-022-01463-9","article-title":"Assessing the treatment pattern, health care resource utilisation, and economic burden of multiple myeloma in France using the Syst\u00e8me National des Donn\u00e9es de Sant\u00e9 (SNDS) database: a retrospective cohort study","volume":"24","author":"Bessou","year":"2023","journal-title":"Eur J Health Econ HEPAC Health Econ Prev Care"},{"key":"10.1016\/j.radonc.2024.110116_b0175","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1016\/j.jval.2021.05.004","article-title":"Estimation of the width of uncertainty in care consumption and costs when using common data collection tools in economic evaluations: a benchmark for sensitivity analyses","volume":"24","author":"Daval","year":"2021","journal-title":"Value Health J Int Soc Pharmacoecon Outcomes Res"},{"key":"10.1016\/j.radonc.2024.110116_b0180","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/hec.584","article-title":"The death of cost-minimization analysis?","volume":"10","author":"Briggs","year":"2001","journal-title":"Health Econ"},{"key":"10.1016\/j.radonc.2024.110116_b0185","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jval.2015.02.001","article-title":"Cost-effectiveness analysis alongside clinical trials II-An ISPOR Good Research Practices Task Force report","volume":"18","author":"Ramsey","year":"2015","journal-title":"Value Health J Int Soc Pharmacoecon Outcomes Res"},{"key":"10.1016\/j.radonc.2024.110116_b0190","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/hec.1812","article-title":"Cost-minimisation analysis versus cost-effectiveness analysis, revisited","volume":"22","author":"Dakin","year":"2013","journal-title":"Health Econ"},{"key":"10.1016\/j.radonc.2024.110116_b0195","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.radonc.2019.09.020","article-title":"Critical review and quality-assessment of cost analyses in radiotherapy: how reliable are the data?","volume":"141","author":"Defourny","year":"2019","journal-title":"Radiother Oncol J Eur Soc Ther Radiol Oncol"},{"key":"10.1016\/j.radonc.2024.110116_b0200","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.radonc.2019.06.015","article-title":"National costs and resource requirements of external beam radiotherapy: a time-driven activity-based costing model from the ESTRO-HERO project","volume":"138","author":"Defourny","year":"2019","journal-title":"Radiother Oncol J Eur Soc Ther Radiol Oncol"},{"key":"10.1016\/j.radonc.2024.110116_b0205","first-page":"33","article-title":"Time-driven activity-based costing of CT-guided vs MR-guided prostate SBRT","volume":"10","author":"Parikh","year":"2021","journal-title":"Appl Radiat Oncol"},{"key":"10.1016\/j.radonc.2024.110116_b0210","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.radonc.2021.08.002","article-title":"Innovation, value and reimbursement in radiation and complex surgical oncology: time to rethink","volume":"169","author":"Borras","year":"2022","journal-title":"Radiother Oncol J Eur Soc Ther Radiol Oncol"},{"key":"10.1016\/j.radonc.2024.110116_b0215","unstructured":"Borras JM, Lievens Y, Coll C, Denjoy N, Espin\u00e0s JA, Figueras J, et al. Tackling reimbursement for radiation oncology and cancer surgery: challenges and options; 2020."},{"key":"10.1016\/j.radonc.2024.110116_b0220","doi-asserted-by":"crossref","first-page":"e1949","DOI":"10.1200\/OP.21.00298","article-title":"Impact of radiation oncology alternative payment model on community cancer centers","volume":"17","author":"Meeks","year":"2021","journal-title":"JCO Oncol Pract"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814024000379?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814024000379?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T05:27:35Z","timestamp":1759123655000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814024000379"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":44,"alternative-id":["S0167814024000379"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2024.110116","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cost-effectiveness of weekly adaptive radiotherapy versus standard IMRT in head and neck cancer alongside the ARTIX trial","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2024.110116","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"110116"}}